Sung-Sun Cho

Amministratore Delegato presso YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.

68 anni

Health Technology

Finance

Profilo

Sung-Sun Cho is currently the Chief Executive Officer and Director at Yuanta 4 SPECIAL PURPOSE ACQUISITION Co., Ltd.
Prior to this, Mr. Cho was the Chief Executive Officer at ProCell Therapeutics, Inc.

Posizioni attive di Sung-Sun Cho

Società	Posizione	Inizio
YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.	Amministratore Delegato	-

Tutte le posizioni attive di Sung-Sun Cho

Precedenti posizioni note di Sung-Sun Cho

Società	Posizione	Fine
ProCell Therapeutics, Inc. ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea.	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Sung-Sun Cho

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Sung-Sun Cho

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.	Finance

Aziende private	1
ProCell Therapeutics, Inc. ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea.	Health Technology